Core Insights - The company announced that it has not yet utilized AI methods in the production process of raw materials [2] - The establishment of Jinhe Bio in 2023 aims to apply synthetic biology in the production of raw materials [2] - The company has achieved full enzyme-based production processes for cephalosporin raw materials, leading to cost reduction and efficiency improvement [2] - In preliminary research for penicillin raw materials, Jinhe Bio has completed enzyme process validation for products like amoxicillin and has developed the capability for independent enzyme preparation [2]